BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response

BACKGROUND: Data on the safety and efficacy of SARS-CoV-2 vaccines in immunocompromised populations are sparse. METHODS: We conducted a prospective study of 77 heart transplant (HT) recipients vaccinated with two doses of BNT162b2 vaccine and monitored for adverse events following both doses, the re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Heart Lung Transplant
Main Authors: Peled, Yael, Ram, Eilon, Lavee, Jacob, Sternik, Leonid, Segev, Amit, Wieder-Finesod, Anat, Mandelboim, Michal, Indenbaum, Victoria, Levy, Itzchak, Raanani, Ehud, Lustig, Yaniv, Rahav, Galia
Formato: Artigo
Idioma:Inglês
Publicado em: International Society for Heart and Lung Transplantation. 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8058049/
https://ncbi.nlm.nih.gov/pubmed/34034958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.healun.2021.04.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados